\
&
Contact us
\
&
Contact us
Starts in 1 week from now
LocationOnline
ProgrammesThis webinar will discuss how AI - particularly generative models - can support clinical decision-making, optimize clinical trial design, and bridge the gap between research and real-world medical practice.
Speaker: Stéphanie Allassonnière, Professor of Applied Mathematics at the School of Medicine, Université Paris Cité, Paris and University's Vice-President in charge of research economical transfer and industrial partnerships.
This session continues the ERA4Health webinar series on the most pressing topics in AI for research and medicine. Find out more on the ERA4Health event page.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
